Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FSGS”

121 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 121 results

Early research (Phase 1)Study completedNCT02693366
What this trial is testing

Stem Cell Therapy for Patients With Focal Segmental Glomerulosclerosis

Who this might be right for
Focal Segmental GlomerulosclerosisChronic Kidney Diseases
Universidade Federal do Rio de Janeiro 5
Testing effectiveness (Phase 2)Looking for participantsNCT05003986
What this trial is testing

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

Who this might be right for
Focal Segmental GlomerulosclerosisMinimal Change DiseaseImmunoglobulin A Nephropathy+2 more
Travere Therapeutics, Inc. 67
Post-approval studies (Phase 4)WithdrawnNCT02399462
What this trial is testing

Acthar for Treatment of Post-transplant FSGS

Who this might be right for
FSGSRenal TransplantationKidney Transplantation
University of North Carolina, Chapel Hill
Early research (Phase 1)Active Not RecruitingNCT06799520
What this trial is testing

Trial to Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of VIS171 in Participants With Autoimmune Disease(s)

Who this might be right for
Systemic Lupus Erythematosus (SLE)Alopecia Areata (AA)Immune-mediated Focal Segmental Glomerulosclerosis (FSGS)
Otsuka Pharmaceutical Development & Commercialization, Inc. 30
Early research (Phase 1)Study completedNCT00353535
What this trial is testing

Total Lymphoid Irradiation (TLI) to Prevent Focal Segmental Glomerulosclerosis (FSGS)Recurrence in the Renal Graft

Who this might be right for
Glomerulosclerosis, Focal
University of Sao Paulo 10
Not applicableUnknownNCT05383547
What this trial is testing

Bortezomib for Treating Glomerular Diseases

Who this might be right for
BortezomibGlomerulonephritisMN+3 more
Ruijin Hospital 20
Early research (Phase 1)Looking for participantsNCT07267026
What this trial is testing

Evaluate the Safety, Tolerability and PK of SK-09

Who this might be right for
FSGSMCD
Consun Pharmaceutical Group 84
Testing effectiveness (Phase 2)Study completedNCT02592798
What this trial is testing

Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)

Who this might be right for
Nephrotic SyndromeFocal Segmental GlomerulosclerosisMinimal Change Disease
Bristol-Myers Squibb 36
Testing effectiveness (Phase 2)Study completedNCT01613118
What this trial is testing

Randomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental Glomerulosclerosis

Who this might be right for
Focal Segmental Glomerulosclerosis
Travere Therapeutics, Inc. 109
Early research (Phase 1)Study completedNCT03970122
What this trial is testing

FIH Ph 1 Study of TRPC5 Channel Inhibitor GFB-887 in Healthy Subjects

Who this might be right for
Healthy Volunteers
Goldfinch Bio, Inc. 70
Not applicableUnknownNCT00956059
What this trial is testing

Therapeutic Effect of Low-dose Prednisone Combined With MMF and FK506 in Focal Segmental Glomerulosclerosis

Who this might be right for
Focal Segmental Glomerulosclerosis
Xi'an Jiaotong University 40
Testing effectiveness (Phase 2)Study completedNCT05237388
What this trial is testing

Janus Kinase-STAT Inhibition to Reduce APOL1 Associated Kidney Disease

Who this might be right for
Chronic Kidney Diseases
Duke University 8
Not applicableActive Not RecruitingNCT02194582
What this trial is testing

Genetic Causes of FSGS, Nephrotic Syndrome, or Kidney Failure

Who this might be right for
Focal Segmental GlomerulosclerosisNephrotic SyndromeEnd Stage Renal Disease+2 more
Beth Israel Deaconess Medical Center 2,050
Not applicableLooking for participantsNCT05505500
What this trial is testing

Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.

Who this might be right for
Fluid OverloadGlomerulosclerosis, Focal SegmentalEdema+10 more
University of Michigan 150
Large-scale testing (Phase 3)Looking for participantsNCT05183646
What this trial is testing

The Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB

Who this might be right for
FSGS
Dimerix Bioscience Pty Ltd 286
Not applicableLooking for participantsNCT04571658
What this trial is testing

NEPTUNE Match Study

Who this might be right for
Nephrotic Syndrome in ChildrenFocal Segmental GlomerulosclerosisMinimal Change Disease+6 more
University of Michigan 375
Not applicableStudy completedNCT01370200
What this trial is testing

Regional Citrate Anticoagulation in Plasma Exchange Treatment

Who this might be right for
Focal Segmental GlomerulosclerosisGuillain-Barre Syndrome
University Medical Centre Ljubljana 140
Not applicableLooking for participantsNCT01094327
What this trial is testing

Proteinuria in Pre and Post Transplant

Who this might be right for
Proteinuria
University of Miami 100
Not applicableStudy completedNCT01835639
What this trial is testing

Vitamin D Supplementation in Glomerular Disease

Who this might be right for
Glomerular Disease
Children's Hospital of Philadelphia 32
Not applicableLooking for participantsNCT03949972
What this trial is testing

The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)

Who this might be right for
Glomerulosclerosis, Focal SegmentalMinimal Change DiseaseIdiopathic Nephrotic Syndrome
Prof. Dr. Paul Brinkkoetter 500
Next Page